Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10939)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 15, 2016 (publication date) through Feb 17, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Thillai K, Ross P, Sarker D. Molecularly targeted therapy for advanced hepatocellular carcinoma - a drug development crisis? World J Gastrointest Oncol 2016; 8(2): 173-185 [PMID: 26909132 DOI: 10.4251/wjgo.v8.i2.173] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v8/i2/173.htm |
| Number | Citing Articles |
| 1 |
Melanie B. Thomas, Elizabeth Garrett-Mayer, Munazza Anis, Kate Anderton, Tricia Bentz, Andie Edwards, Alan Brisendine, Geoffrey Weiss, Abby B. Siegel, Johanna Bendell, Ari Baron, Vinay Duddalwar, Anthony El-Khoueiry. A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma. Oncology 2018; 94(6): 329 doi: 10.1159/000485384
|
| 2 |
Hyo Jeong Kang, Ji-Hye Oh, Sung-Min Chun, Deokhoon Kim, Yeon-Mi Ryu, Hee Sang Hwang, Sang-Yeob Kim, Jihyun An, Eun Jeong Cho, Hyeonjin Lee, Ju Hyun Shim, Chang Ohk Sung, Eunsil Yu. Immunogenomic landscape of hepatocellular carcinoma with immune cell stroma and EBV-positive tumor-infiltrating lymphocytes. Journal of Hepatology 2019; 71(1): 91 doi: 10.1016/j.jhep.2019.03.018
|
| 3 |
Srinivas Chava, Christine Lee, Yucel Aydin, Partha K. Chandra, Asha Dash, Milad Chedid, Swan N. Thung, Krzysztof Moroz, Tong Wu, Nabeen C. Nayak, Srikanta Dash. Chaperone-mediated autophagy compensates for impaired macroautophagy in the cirrhotic liver to promote hepatocellular carcinoma. Oncotarget 2017; 8(25): 40019 doi: 10.18632/oncotarget.16685
|
| 4 |
Xiao-Qin He, Yue-Feng Zhang, Jia-Jun Yu, Yuan-Yuan Gan, Na-Na Han, Mei-Xia Zhang, Wei Ge, Jun-Jian Deng, Yong-Fa Zheng, Xi-Ming Xu. High expression of G-protein signaling modulator 2 in hepatocellular carcinoma facilitates tumor growth and metastasis by activating the PI3K/AKT signaling pathway. Tumor Biology 2017; 39(3): 101042831769597 doi: 10.1177/1010428317695971
|
| 5 |
Valerie Fako, Xin Wei Wang. The status of transarterial chemoembolization treatment in the era of precision oncology. Hepatic Oncology 2017; 4(2): 55 doi: 10.2217/hep-2017-0009
|
| 6 |
Chunzhi Meng, Hongyi Li, Chen Chen, Wei Wu, Jing Gao, Yining Lai, Mila Ka, Min Zhu, Xiaoyi Lv, Fangfang Chen, Cheng Chen. Serum Raman spectroscopy combined with Gaussian—convolutional neural network models to quickly detect liver cancer patients. Spectroscopy Letters 2022; 55(2): 79 doi: 10.1080/00387010.2022.2027988
|
| 7 |
Liliana Montella, Giovannella Palmieri, Raffaele Addeo, Salvatore Del Prete. Hepatocellular carcinoma: Will novel targeted drugs really impact the next future?. World Journal of Gastroenterology 2016; 22(27): 6114-6126 doi: 10.3748/wjg.v22.i27.6114
|
| 8 |
Changhoon Choi, Arang Son, Hyi-Seung Lee, Yeon-Ju Lee, Hee Chul Park. Radiosensitization by Marine Sponge Agelas sp. Extracts in Hepatocellular Carcinoma Cells with Autophagy Induction. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-24745-w
|
| 9 |
Giandomenico Roviello, Laura Zanotti, Maria Rosa Cappelletti, Angela Gobbi, Giulia Borsella, Chiara Pacifico, Andrea Giovanni Multari, Daniele Generali. New molecular therapies in patients with advanced Hepatocellular Cancer in second line of treatment: Is a real defeat?: Results from a literature based meta-analysis of randomized trials. Critical Reviews in Oncology/Hematology 2016; 108: 62 doi: 10.1016/j.critrevonc.2016.10.015
|
| 10 |
R.K. Kelley, C. Verslype, A.L. Cohn, T.-S. Yang, W.-C. Su, H. Burris, F. Braiteh, N. Vogelzang, A. Spira, P. Foster, Y. Lee, E. Van Cutsem. Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study. Annals of Oncology 2017; 28(3): 528 doi: 10.1093/annonc/mdw651
|
| 11 |
Nimisha Roy, Utkarsh Raj, Sneha Rai, Pritish K. Varadwaj. Deciphering the Novel Target Genes Involved in the Epigenetics of Hepatocellular Carcinoma Using Graph Theory Approach. Current Genomics 2020; 20(8): 545 doi: 10.2174/1389202921666191227100441
|
| 12 |
Xiaofei Li, Daofu Zhang, Shan Guan, Weiwei Ye, Liwen Liu, Lianqing Lou. Efficacy of anti-VEGF agents in the treatment of elderly hepatocellular carcinoma: a systematic review. Oncotarget 2017; 8(54): 93179 doi: 10.18632/oncotarget.21452
|
| 13 |
Xiaolan Yin, Yanan Xiao, Leiqiang Han, Bo Zhang, Tianqi Wang, Zhihui Su, Na Zhang. Ceramide-Fabricated Co-Loaded Liposomes for the Synergistic Treatment of Hepatocellular Carcinoma. AAPS PharmSciTech 2018; 19(5): 2133 doi: 10.1208/s12249-018-1005-4
|
| 14 |
Bin Chen, Lana Garmire, Diego F. Calvisi, Mei-Sze Chua, Robin K. Kelley, Xin Chen. Harnessing big ‘omics’ data and AI for drug discovery in hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology 2020; 17(4): 238 doi: 10.1038/s41575-019-0240-9
|
| 15 |
Margherita Correnti, Chiara Raggi. Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancer. Oncotarget 2017; 8(4): 7094 doi: 10.18632/oncotarget.12569
|
| 16 |
Gunnar Folprecht, Michael Geißler, Christian Jehn, Diana Lüftner, Helmut Oettle. Facharztwissen Hämatologie Onkologie. 2017; : 605 doi: 10.1016/B978-3-437-21214-7.00017-1
|
| 17 |
Yi Shi, Xiaofei Mo, Simei Hong, Tianbao Li, Baozhen Chen, Gang Chen, Zhenguo Zhang. [Retracted] Studying the Role and Molecular Mechanisms of MAP4K3 in Sorafenib Resistance of Hepatocellular Carcinoma. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/4965670
|
| 18 |
Hanqiu Tang, Xiaotao Li, Rui Yang. Downregulation of microRNA-143 promotes cell proliferation by regulating PKCε in hepatocellular carcinoma cells. Molecular Medicine Reports 2017; 16(4): 4348 doi: 10.3892/mmr.2017.7092
|
| 19 |
Chengjie Lin, Zhigao Hu, Biao Lei, Bo Tang, Hongping Yu, Xiaoqiang Qiu, Songqing He. Overexpression of Yes‐associated protein and its association with clinicopathological features of hepatocellular carcinoma: A meta‐analysis. Liver International 2017; 37(11): 1675 doi: 10.1111/liv.13428
|
| 20 |
Giandomenico Roviello, Navid Sohbani, Roberto Petrioli, Maria Grazia Rodriquenz. Ramucirumab as a second line therapy for advanced HCC: a significant achievement or a wasted opportunity for personalised therapy?. Investigational New Drugs 2019; 37(6): 1274 doi: 10.1007/s10637-019-00760-0
|
| 21 |
Laure de Rosamel, Jean-Frederic Blanc. Emerging tyrosine kinase inhibitors for the treatment of hepatocellular carcinoma. Expert Opinion on Emerging Drugs 2017; 22(2): 175 doi: 10.1080/14728214.2017.1336538
|
| 22 |
Chang Liu, Xiuli Mu, Xuan Wang, Chan Zhang, Lina Zhang, Baofeng Yu, Gongqin Sun. Ponatinib Inhibits Proliferation and Induces Apoptosis of Liver Cancer Cells, but Its Efficacy Is Compromised by Its Activation on PDK1/Akt/mTOR Signaling. Molecules 2019; 24(7): 1363 doi: 10.3390/molecules24071363
|
| 23 |
Shuo Zhu, Shengya Cao, Weibin Yang, Jinhui Che, Deqiang Li, Ruifeng Pei, Yiren Ding. The Maturation of Tumor Suppressor miR-497 in Hepatocellular Carcinoma is Inhibited by Oncogenic circRNA SCARB1. Cancer Management and Research 2021; : 5751 doi: 10.2147/CMAR.S304125
|
| 24 |
Samrat Chakraborty, Zewdu Yilma Dlie, Biswajit Mukherjee, Shila Elizabeth Besra, Soma Sengupta, Ramkrishna Sen, Alankar Mukherjee. A Comparative Investigation of the Ability of Various Aptamer-Functionalized Drug Nanocarriers to Induce Selective Apoptosis in Neoplastic Hepatocytes: In Vitro and In Vivo Outcome. AAPS PharmSciTech 2020; 21(3) doi: 10.1208/s12249-020-1629-z
|
| 25 |
Mohammad K. Mohammad, Guoli Chen. Practical Oncologic Molecular Pathology. 2021; : 171 doi: 10.1007/978-3-030-73227-1_8
|
| 26 |
Jonghwan Choi, Sanghyun Park, Jaegyoon Ahn. RefDNN: a reference drug based neural network for more accurate prediction of anticancer drug resistance. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-58821-x
|